JTO Clinical and Research Reports: Volume 3 (Issue 1 to Issue 12) 

Journal Spotlight: JTO Clinical and Research Reports

JTO Clinical and Research Reports is the official open access journal of the International Association for the Study of Lung Cancer (IASLC). This journal serves as a valuable complement to the Journal of Thoracic Oncology by offering authors a gold open access publication option. It’s a go-to platform for sharing critical research in the field of lung cancer. Here’s why JTO CRR stands out:

Key Features:

1. Official IASLC Journal: JTO CRR is the authorized publication of the IASLC, a globally recognized authority in lung cancer research and care.
2. Gold Open Access: This journal provides gold open access, ensuring that research is immediately and permanently free to access by all interested parties. This open access model democratizes knowledge sharing.
3. Diverse Article Types: JTO CRR welcomes a range of article types, including:
   • Phase I trials: Investigating the safety and dosages of new treatments.
   • Single-arm phase II trials: Assessing the efficacy of new treatments.
   • Subset analyses of published trials: Providing deeper insights into clinical trial data.
   • Retrospective Studies: Examining patient data to identify trends and outcomes.
   • Database analysis: Utilizing large datasets to generate insights.
   • Large institutional series: Sharing findings from comprehensive institutional studies.
   • High-quality case reports: Detailing unique and impactful cases.
   • Region-specific clinical trials: Exploring clinical trials relevant to specific geographic regions.
   • Subspecialty thoracic oncology studies: Covering niche areas within the field.
   • Meeting reports: Summarizing key findings from high-quality meetings and conferences.

Accessible Research: By covering publication costs through author fees, JTO CRR ensures that published research is open to everyone. This accessibility helps researchers, healthcare professionals, and the public stay informed about the latest developments in lung cancer care and research.

IASLC and JTO CRR are dedicated to advancing the understanding of lung cancer, improving patient care, and promoting international collaboration among researchers and healthcare professionals.

If you have any specific questions about this journal or require additional information, please feel free to ask.